Page last updated: 2024-08-26

bosentan anhydrous and Limited Scleroderma

bosentan anhydrous has been researched along with Limited Scleroderma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bootsma, H; Hettema, ME; Kallenberg, CG; Smit, AJ; Stienstra, Y; Zhang, D1
Weinerth, J; Wiesent, F1
Hall, FC; Ostor, AJ; Yu, EP1

Trials

1 trial(s) available for bosentan anhydrous and Limited Scleroderma

ArticleYear
No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis.
    Clinical rheumatology, 2009, Volume: 28, Issue:7

    Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Immunosuppressive Agents; Laser-Doppler Flowmetry; Male; Microcirculation; Microscopic Angioscopy; Middle Aged; Nails; Outpatients; Pilot Projects; Raynaud Disease; Regional Blood Flow; Scleroderma, Limited; Sulfonamides; Treatment Outcome; Vasodilation

2009

Other Studies

2 other study(ies) available for bosentan anhydrous and Limited Scleroderma

ArticleYear
[Digital ulcers in systemic sclerosis--an interdisciplinary challenge].
    Medizinische Klinik (Munich, Germany : 1983), 2010, Volume: 105, Issue:8

    Topics: Angiography; Antihypertensive Agents; Arm; Bosentan; Cooperative Behavior; CREST Syndrome; Endothelin Receptor Antagonists; Fatal Outcome; Fingers; Follow-Up Studies; Hand Dermatoses; Humans; Iloprost; Interdisciplinary Communication; Leg; Male; Middle Aged; Scleroderma, Limited; Skin Ulcer; Sulfonamides; Vasodilator Agents

2010
Successful treatment with bosentan for severe digital ischaemia in limited cutaneous systemic sclerosis.
    Annals of the rheumatic diseases, 2007, Volume: 66, Issue:8

    Topics: Adult; Bosentan; Fingers; Humans; Ischemia; Male; Scleroderma, Limited; Sulfonamides; Vasodilator Agents

2007